Humana Inc (HUM)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Humana Inc (HUM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8012226
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月14日
◆ページ数:103
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Humana Inc (Humana) is a health and well-being company that offers health insurance and Medicare plans, insurance products, and health and wellness services to healthcare providers, employers, individuals, administrators, government, and the public sector. The company’s Medicare products and services include Medicare Advantage plan, prescription drug plan, Medicare supplement insurance plans, group Medicare advantage plan and Medicare plan tools. It offers products and services for individual and family including medical plans, dental plans, vision plans, life insurance and life and supplemental plans, among others. The company sells its products in the US through direct sales representatives and telemarketing representatives, licensed independent brokers and agents and marketing arrangement with Wal-Mart Stores, Inc. Humana is headquartered in Louisville, Kentucky, the US.

Humana Inc (HUM) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Humana Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Humana Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Humana Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Humana Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Humana Inc, Medical Devices Deals, 2011 to YTD 2017 10
Humana Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Humana Inc, Pharmaceuticals & Healthcare, Deal Details 13
Asset Purchase 13
Continucare Acquires Assets Of S.B.B. Medical Group 13
Metropolitan Health Networks Acquires Ladia & Ladia 14
Metcare Of Florida Acquires Dr. Suzann Leslie 15
Metropolitan Health Networks Acquires Medical Practice From Selma C. Delima 16
Venture Financing 17
Omada Health Raises USD48 Million in Series C Financing 17
Partnerships 19
Allergan Enters into Research Agreement with Humana 19
Humana Enters Into Research Agreement With Astellas For Health Care Delivery 20
Humana Enters Into Research Agreement With Novo Nordisk For Diabetes 21
Equity Offering 22
Metropolitan Health Files Registration Statement For Public Offering Of Securities For US$200 Million 22
Acquisition 23
Wal-Mart May Buy Humana for USD46 Billion 23
MJ Acquisition Acquires Concentra for USD1 Billion 24
Humana Acquires Your Home Advantage 26
Humana Acquires Svenska Specialistpsykiatrigruppen From Valedo Partners 27
Humana Acquires American Eldercare, Healthcare Services Provider 28
Humana Completes Acquisition Of Metropolitan Health Networks For US$850 Million 29
Metcare of Florida To Acquire Kanner, Shteiman, Provider Of Healthcare Services 31
Humana Completes Acquisition Of SeniorBridge Family Companies From Caltius Equity Partners 32
Metropolitan Health Completes Acquisition Of Continucare For US$416 Million 33
Humana Inc – Key Competitors 35
Humana Inc – Key Employees 36
Humana Inc – Locations And Subsidiaries 37
Head Office 37
Other Locations & Subsidiaries 37
Recent Developments 43
Strategy And Business Planning 43
May 10, 2017: Humana Brings Value-Based Orthopedic Specialty Care to North Carolina and Virginia 43
May 18, 2016: Humana Brings Value-Based Orthopaedic Specialty Care Model to Tennessee, Expands in Ohio 44
Financial Announcements 45
Nov 08, 2017: Humana Reports Third Quarter 2017 Financial Results 45
Aug 02, 2017: Humana Reports Second Quarter 2017 Financial Results; Raises Full Year 2017 Guidance; Provides Update on Bonus Year 2018 Star Ratings 47
May 03, 2017: Humana Reports Detailed First Quarter Financial Results; Reaffirms Recent Full-Year 2017 EPS Guidance Increase 48
Apr 24, 2017: Humana Pre-announces First Quarter 2017 EPS and Revenues and Increases Full-year 2017 EPS Guidance 49
Feb 08, 2017: Humana Reports Fourth Quarter 2016 Financial Results 50
Nov 04, 2016: Humana Reports Third Quarter 2016 Financial Results 53
Aug 19, 2016: Humana announces financial results for interim period January-June 2016 60
Aug 03, 2016: Humana Reports Second Quarter 2016 Financial Results; Reaffirms Recent 2016 Financial Guidance Increase 64
Jul 21, 2016: Humana Increases Earnings Guidance 74
May 04, 2016: Humana Reports First Quarter 2016 Financial Results; Reaffirms 2016 Financial Guidance 76
Feb 10, 2016: Humana Reports Fourth Quarter 2015 Financial Results; Provides 2016 Financial Guidance 78
Corporate Communications 79
Nov 13, 2017: Humana Elects Karen DeSalvo, M.D., to Board of Directors 79
Aug 21, 2017: Humana appoints new member to board of directors 80
Jun 23, 2017: Humana Names Sam Deshpande Chief Risk Officer 81
Apr 27, 2016: Humana Research on Medication Adherence and Medicare Advantage Wins Prestigious Awards 82
Mar 10, 2016: Humana Named No. 1 U.S. Health Care Company in Leading National Assessment of Corporate Sustainability Efforts 83
Government and Public Interest 84
Jul 18, 2017: Humana Foundation Awards $735,000 to South Florida Nonprofits to Improve Health of Community 84
Jul 12, 2016: Humana Approved for $3.6 Million Research Funding Award by the Patient-Centered Outcomes Research Institute 86
Product News 87
Feb 02, 2017: Study Finds Omada Diabetes Prevention Program Resulted in 7.5% Weight Loss in Humana Medicare Advantage Population 87
Other Significant Developments 88
Oct 26, 2017: New Study Finds Healthy Days Valid Tool for Evaluating Population Health in Medicare Advantage Patients with Chronic Conditions 88
Oct 17, 2017: Humana Expands Medicare Advantage Offerings in New Hampshire 89
Dec 14, 2016: Humana Simplifies Clinical Quality Metrics to Ease Growing Reporting Demands Placed on Physicians 90
Nov 28, 2016: Humana to Add JSA Medical Group’s New Primary Care Practices Designed Exclusively for Medicare Beneficiaries to Florida Medicare Advantage Plan Networks 91
Nov 07, 2016: Humana Adds Telemedicine Technology Benefit in Medicare Advantage Plans Available in Georgia and South Carolina 93
Oct 28, 2016: Humana to Add EliteHealth’s New Primary Care Practices Designed Exclusively for Medicare Beneficiaries to South Florida Medicare Advantage Plan Networks 94
Oct 13, 2016: Humana to Add Iora Health’s New Primary Care Practices Designed Exclusively for Medicare Beneficiaries to Medicare Advantage Plan Networks in Arizona, Colorado and Washington 96
Oct 12, 2016: Humana Comments on Medicare Star Quality Ratings and Raises 2016 Financial Guidance 97
Jun 16, 2016: Humana and Mount Sinai Health Partners Create Improved Care Model 99
May 05, 2016: Hennepin County Medical Center Partnering with Humana on Value-Based Care Initiative 100
Mar 10, 2016: Humana Launches Value-Based Orthopedic Specialty Care Model in Ohio 101
Mar 03, 2016: Humana, DeKalb Medical and DeKalb Physician Hospital Organization Now Offer Value-based Care to Commercial Members 102
Appendix 103
Methodology 103
About GlobalData 103
Contact Us 103
Disclaimer 103

List of Tables
Humana Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Humana Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Humana Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Humana Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Humana Inc, Deals By Therapy Area, 2011 to YTD 2017 9
Humana Inc, Medical Devices Deals, 2011 to YTD 2017 10
Humana Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Continucare Acquires Assets Of S.B.B. Medical Group 13
Metropolitan Health Networks Acquires Ladia & Ladia 14
Metcare Of Florida Acquires Dr. Suzann Leslie 15
Metropolitan Health Networks Acquires Medical Practice From Selma C. Delima 16
Omada Health Raises USD48 Million in Series C Financing 17
Allergan Enters into Research Agreement with Humana 19
Humana Enters Into Research Agreement With Astellas For Health Care Delivery 20
Humana Enters Into Research Agreement With Novo Nordisk For Diabetes 21
Metropolitan Health Files Registration Statement For Public Offering Of Securities For US$200 Million 22
Wal-Mart May Buy Humana for USD46 Billion 23
MJ Acquisition Acquires Concentra for USD1 Billion 24
Humana Acquires Your Home Advantage 26
Humana Acquires Svenska Specialistpsykiatrigruppen From Valedo Partners 27
Humana Acquires American Eldercare, Healthcare Services Provider 28
Humana Completes Acquisition Of Metropolitan Health Networks For US$850 Million 29
Metcare of Florida To Acquire Kanner, Shteiman, Provider Of Healthcare Services 31
Humana Completes Acquisition Of SeniorBridge Family Companies From Caltius Equity Partners 32
Metropolitan Health Completes Acquisition Of Continucare For US$416 Million 33
Humana Inc, Key Competitors 35
Humana Inc, Key Employees 36
Humana Inc, Other Locations 37
Humana Inc, Subsidiaries 40

★海外企業調査レポート[Humana Inc (HUM)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ITM Power Plc (ITM):電力:M&Aディール及び事業提携情報
    Summary ITM Power Plc (ITM Power) is a renewable energy company. It designs and manufactures hydrogen energy systems for clean fuel production and energy storage. The company develops equipment to convert renewable energy into a clean fuel that can be stored for use in transport, industrial, and res …
  • Theraclion SA (ALTHE):企業の財務・戦略的SWOT分析
    Summary Theraclion SA (Theraclion) is a medical device company that designs, markets, and develops high-intensity focused therapeutic ultrasound devices and equipment; and offers technical support services. The company offers echotherapy solution that combines HIFU therapy with ultrasound as a syste …
  • Arsenal Holdings PLC:企業の戦略的SWOT分析
    Arsenal Holdings PLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Spero Therapeutics Inc (SPRO):製薬・医療:M&Aディール及び事業提携情報
    Summary Spero Therapeutics Inc. (Spero) is a clinical-stage biopharmaceutical company. It is engaged in developing, identifying and commercializing novel treatments for multi-drug resistant (MDR) bacterial infections. Its product pipeline includes SPR994 oral gram-negative program, SPR741and SPR206 …
  • Meketa Investment Group:企業の戦略・SWOT・財務情報
    Meketa Investment Group - Strategy, SWOT and Corporate Finance Report Summary Meketa Investment Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Iconic Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Iconic Therapeutics Inc (Iconic Therapeutics) is a biopharmaceutical company that provides translation of scientific insight into breakthrough medicines. The company offers development of tissue factor in inflammation, angiogenesis, and metastasis that led to develop new approach to retinal …
  • Bio-Rad Laboratories Inc (BIO):企業の財務・戦略的SWOT分析
    Bio-Rad Laboratories Inc (BIO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Heidelberg Engineering GmbH:製品パイプライン分析
    Summary Heidelberg Engineering GmbH (Heidelberg Engineering) is a imaging solutions provider that develops, manufactures and distributes diagnostic devices for ophthalmology practice. The company offers various diagnostic instruments for eye care professionals. Its products comprise spectralis, HEP, …
  • Air Transport Services Group, Inc.:企業の戦略・SWOT・財務情報
    Air Transport Services Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Air Transport Services Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Graphic Packaging Holding Company:企業の戦略・SWOT・財務情報
    Graphic Packaging Holding Company - Strategy, SWOT and Corporate Finance Report Summary Graphic Packaging Holding Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • United Engineers Limited:企業の戦略・SWOT・財務情報
    United Engineers Limited - Strategy, SWOT and Corporate Finance Report Summary United Engineers Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • University of Birmingham-医療機器分野:企業M&A・提携分析
    Summary University of Birmingham is an academic research university that offers educational services. The university provides undergraduate, postgraduate, postgraduate research, and distance learning programs. It offers educational courses in various fields including accounting, astronomy, computer …
  • Orange SA:戦略・SWOT・企業財務分析
    Orange SA - Strategy, SWOT and Corporate Finance Report Summary Orange SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • PACCAR Inc.:戦略・SWOT・企業財務分析
    PACCAR Inc. - Strategy, SWOT and Corporate Finance Report Summary PACCAR Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Haisco Pharmaceutical Group Co Ltd (002653)-医療機器分野:企業M&A・提携分析
    Summary Haisco Pharmaceutical Group Co Ltd (Haisco Pharma), formerly Xizang Haisco Pharmaceutical Group Co Ltd is a developer and marketer of chemical drug preparations and bulk drugs. The company's product portfolio comprises injection for trace elements, compound vitamin, invert sugar, fat soluble …
  • West Fraser Timber Co. Ltd. (WFT):企業の財務・戦略的SWOT分析
    West Fraser Timber Co. Ltd. (WFT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Photocure ASA (PHO):企業の財務・戦略的SWOT分析
    Photocure ASA (PHO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • United Overseas Bank Ltd:戦略・SWOT・企業財務分析
    United Overseas Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary United Overseas Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Heineken NV:戦略・SWOT・企業財務分析
    Heineken NV - Strategy, SWOT and Corporate Finance Report Summary Heineken NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Repsol SA (REP):電力:M&Aディール及び事業提携情報
    Summary Repsol SA (Repsol) is an integrated oil and gas company. It has presence across the entire value chain: exploration and production, transformation, development and marketing of energy. The company’s upstream business carries out oil and natural gas exploration and production. Its downstream …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆